FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2359884680> ?p ?o ?g. }

• W2359884680 endingPage "2613" @default.
• W2359884680 startingPage "2605" @default.
• W2359884680 abstract "Background Platelet transfusion after acute spontaneous primary intracerebral haemorrhage in people taking antiplatelet therapy might reduce death or dependence by reducing the extent of the haemorrhage. We aimed to investigate whether platelet transfusion with standard care, compared with standard care alone, reduced death or dependence after intracerebral haemorrhage associated with antiplatelet therapy use. Methods We did this multicentre, open-label, masked-endpoint, randomised trial at 60 hospitals in the Netherlands, UK, and France. We enrolled adults within 6 h of supratentorial intracerebral haemorrhage symptom onset if they had used antiplatelet therapy for at least 7 days beforehand and had a Glasgow Coma Scale score of at least 8. With use of a secure web-based system that concealed allocation and used biased coin randomisation, study collaborators randomly assigned participants (1:1; stratified by hospital and type of antiplatelet therapy) to receive either standard care or standard care with platelet transfusion within 90 min of diagnostic brain imaging. Participants and local investigators giving interventions were not masked to treatment allocation, but allocation was concealed from outcome assessors and investigators analysing data. The primary outcome was shift towards death or dependence rated on the modified Rankin Scale (mRS) at 3 months, and analysed by ordinal logistic regression, adjusted for stratification variables and the Intracerebral Haemorrhage Score. The primary analysis was done in the intention-to-treat population and safety analyses were done in the intention-to-treat and as-treated populations. This trial is registered with the Netherlands Trial Register, number NTR1303, and is now closed. Findings Between Feb 4, 2009, and Oct 8, 2015, 41 sites enrolled 190 participants. 97 participants were randomly assigned to platelet transfusion and 93 to standard care. The odds of death or dependence at 3 months were higher in the platelet transfusion group than in the standard care group (adjusted common odds ratio 2·05, 95% CI 1·18–3·56; p=0·0114). 40 (42%) participants who received platelet transfusion had a serious adverse event during their hospital stay, as did 28 (29%) who received standard care. 23 (24%) participants assigned to platelet transfusion and 16 (17%) assigned to standard care died during hospital stay. Interpretation Platelet transfusion seems inferior to standard care for people taking antiplatelet therapy before intracerebral haemorrhage. Platelet transfusion cannot be recommended for this indication in clinical practice. Funding The Netherlands Organisation for Health Research and Development, Sanquin Blood Supply, Chest Heart and Stroke Scotland, French Ministry of Health." @default.
• W2359884680 created "2016-06-24" @default.
• W2359884680 creator A5001471568 @default.
• W2359884680 creator A5009702648 @default.
• W2359884680 creator A5018998576 @default.
• W2359884680 creator A5020918126 @default.
• W2359884680 creator A5023457875 @default.
• W2359884680 creator A5024309954 @default.
• W2359884680 creator A5034088593 @default.
• W2359884680 creator A5043499668 @default.
• W2359884680 creator A5055144535 @default.
• W2359884680 creator A5074944516 @default.
• W2359884680 creator A5077611966 @default.
• W2359884680 creator A5081542140 @default.
• W2359884680 creator A5083387295 @default.
• W2359884680 date "2016-06-01" @default.
• W2359884680 modified "2023-10-18" @default.
• W2359884680 title "Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial" @default.
• W2359884680 cites W151371462 @default.
• W2359884680 cites W1566712571 @default.
• W2359884680 cites W1603896514 @default.
• W2359884680 cites W1866068290 @default.
• W2359884680 cites W1947113872 @default.
• W2359884680 cites W1994990224 @default.
• W2359884680 cites W2037535652 @default.
• W2359884680 cites W2056544949 @default.
• W2359884680 cites W2057409224 @default.
• W2359884680 cites W2060980430 @default.
• W2359884680 cites W2069758692 @default.
• W2359884680 cites W2072154493 @default.
• W2359884680 cites W2083600673 @default.
• W2359884680 cites W2091313310 @default.
• W2359884680 cites W2094585602 @default.
• W2359884680 cites W2100089051 @default.
• W2359884680 cites W2111926401 @default.
• W2359884680 cites W2112161237 @default.
• W2359884680 cites W2113333920 @default.
• W2359884680 cites W2122158384 @default.
• W2359884680 cites W2128178138 @default.
• W2359884680 cites W2130530616 @default.
• W2359884680 cites W2135796724 @default.
• W2359884680 cites W2145121403 @default.
• W2359884680 cites W2157595656 @default.
• W2359884680 cites W2158474808 @default.
• W2359884680 cites W2169423935 @default.
• W2359884680 cites W2169670745 @default.
• W2359884680 cites W2170138525 @default.
• W2359884680 cites W4241306296 @default.
• W2359884680 doi "https://doi.org/10.1016/s0140-6736(16)30392-0" @default.
• W2359884680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27178479" @default.
• W2359884680 hasPublicationYear "2016" @default.
• W2359884680 type Work @default.
• W2359884680 sameAs 2359884680 @default.
• W2359884680 citedByCount "529" @default.
• W2359884680 countsByYear W23598846802016 @default.
• W2359884680 countsByYear W23598846802017 @default.
• W2359884680 countsByYear W23598846802018 @default.
• W2359884680 countsByYear W23598846802019 @default.
• W2359884680 countsByYear W23598846802020 @default.
• W2359884680 countsByYear W23598846802021 @default.
• W2359884680 countsByYear W23598846802022 @default.
• W2359884680 countsByYear W23598846802023 @default.
• W2359884680 crossrefType "journal-article" @default.
• W2359884680 hasAuthorship W2359884680A5001471568 @default.
• W2359884680 hasAuthorship W2359884680A5009702648 @default.
• W2359884680 hasAuthorship W2359884680A5018998576 @default.
• W2359884680 hasAuthorship W2359884680A5020918126 @default.
• W2359884680 hasAuthorship W2359884680A5023457875 @default.
• W2359884680 hasAuthorship W2359884680A5024309954 @default.
• W2359884680 hasAuthorship W2359884680A5034088593 @default.
• W2359884680 hasAuthorship W2359884680A5043499668 @default.
• W2359884680 hasAuthorship W2359884680A5055144535 @default.
• W2359884680 hasAuthorship W2359884680A5074944516 @default.
• W2359884680 hasAuthorship W2359884680A5077611966 @default.
• W2359884680 hasAuthorship W2359884680A5081542140 @default.
• W2359884680 hasAuthorship W2359884680A5083387295 @default.
• W2359884680 hasBestOaLocation W23598846803 @default.
• W2359884680 hasConcept C126322002 @default.
• W2359884680 hasConcept C127413603 @default.
• W2359884680 hasConcept C141071460 @default.
• W2359884680 hasConcept C168563851 @default.
• W2359884680 hasConcept C17624336 @default.
• W2359884680 hasConcept C187212893 @default.
• W2359884680 hasConcept C194828623 @default.
• W2359884680 hasConcept C203092338 @default.
• W2359884680 hasConcept C2776689292 @default.
• W2359884680 hasConcept C2780645631 @default.
• W2359884680 hasConcept C2780931571 @default.
• W2359884680 hasConcept C2908647359 @default.
• W2359884680 hasConcept C3020199598 @default.
• W2359884680 hasConcept C541997718 @default.
• W2359884680 hasConcept C71924100 @default.
• W2359884680 hasConcept C78519656 @default.
• W2359884680 hasConcept C89560881 @default.
• W2359884680 hasConcept C99454951 @default.
• W2359884680 hasConceptScore W2359884680C126322002 @default.
• W2359884680 hasConceptScore W2359884680C127413603 @default.
• W2359884680 hasConceptScore W2359884680C141071460 @default.

• next